Eli Lilly

Metabolic breakthroughs that work

Indianapolis, Indiana, USA

Eli Lilly and Company is a global healthcare company with a rich history of pharmaceutical innovation, focused on discovering, developing, manufacturing, and selling innovative pharmaceutical products. They specialize in therapeutic areas with unmet medical needs, leveraging advanced technologies like AI in drug discovery and manufacturing, and expanding distribution through platforms like LillyDirect.

Shareable draft

Check out Eli Lilly on @MedStartr Today Eli Lilly and Company is a global healthcare company with a rich history of pharmaceutical innovation, focused on discovering, developing, manufacturing, and selling innovative pharmaceutical products. They specialize in therapeutic areas with unmet medical needs, leveraging advanced technologies like AI in drug discovery and manufacturing, and expanding distribution through platforms like LillyDirect. #DiabetesAndObesity #Immunology #Neuroscience #Pain #MentalBehavioralHealth #CancerOncology #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/F1WVtwTr3D0

Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.

Get Involved in Eli Lilly

How We Help

Problem Statement

Eli Lilly aims to solve significant unmet medical needs by discovering, developing, and providing innovative pharmaceutical products to improve patient health outcomes.

Core Technology

Biotechnology, chemistry, genetic medicine, Artificial Intelligence (AI) and machine learning in drug discovery and optimization, supercomputers for AI compute capacity, and innovative pill capsule manufacturing.

Key Differentiators

Significant R&D Investment, Therapeutic Specialization and Product Success (e.g., Mounjaro, Zepbound), Strong Intellectual Property, Manufacturing Scale and Capacity, Strategic Partnerships and Alliances, Focus on Innovation and Quality, Digital Transformation and AI Integration.

Clinical Focus

Diabetes and Obesity (Cardiometabolic health), Oncology (Cancer), Immunology, Neuroscience (including neurodegeneration like Alzheimer's disease), Pain.

Target Customers

Patients (directly via LillyDirect), healthcare providers (physicians), pharmacies, hospitals/health systems, and distributors.

Product Stage

Mature

Company Info

Business Model: Pharmaceutical development and sales (B2B/B2C hybrid), characterized by extensive R&D, global sales and marketing, strategic partnerships, and direct-to-consumer distribution platforms.
Founded: 1876
Website: www.lilly.com

Disease Areas

Diabetes and Obesity Immunology Neuroscience Pain Mental Health Cancer & Oncology

Technologies

BiotechnologyChemistryMachine LearningSupercomputingPharmaceutical ManufacturingGenetic MedicinesAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Zepbound FDA-approved Nov 2023. Mounjaro FDA-approved May 2022. Retatrutide Phase 3: 15.3% weight loss, 1.9% HbA1C. Orforglipron FDA priority review Q2 2026.

🛡️

IP Protection

Strong Intellectual Property

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Eli Lilly?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.